StockComparison Logo
vs

SNY vs GSK

Comparison between Sanofi (SNY, Company) and GSK Plc (GSK, Company).

Both SNY and GSK are from the Healthcare sector.

5-Year PerformanceGSK has outperformed SNY, delivering a return of +4.8% compared to +0.1%

SNY vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
SNY
$105B
GSK
$104B
Max Drawdown
Winner
SNY
49.96%
GSK
64.03%
Sharpe Ratio
SNY
-0.26
Winner
GSK
1.03
5Y Beta
SNY
0.31
Winner
GSK
0.25
Industry
SNY
Drug Manufacturers - General
GSK
Drug Manufacturers - General
P/E Ratio
SNY
12.09
Winner
GSK
12.04
Forward P/E
Winner
SNY
8.87
GSK
11.38
PEG Ratio
SNY
0.39
Winner
GSK
0.10
Dividend Yield
Winner
SNY
8.81%
GSK
3.40%
5Y Dividends CAGR
Winner
SNY
19.45%
GSK
1.34%
5Y EPS CAGR
SNY
-8.34%
Winner
GSK
4.65%
Debt to Equity
Winner
SNY
27.50%
GSK
106.74%
Free Cash Flow Yield
Winner
SNY
8.52%
GSK
8.07%
P/S Ratio
Winner
SNY
2.26
GSK
3.13
P/B Ratio
Winner
SNY
1.28
GSK
4.31

SNY vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
SNY
+2.60%
Winner
GSK
+5.15%
3M
Winner
SNY
+5.16%
GSK
-2.09%
6M
SNY
-3.29%
Winner
GSK
+7.79%
1Y
SNY
-6.40%
Winner
GSK
+33.69%
5Y(CAGR)
SNY
+0.14%
Winner
GSK
+4.81%
10Y(CAGR)
Winner
SNY
+5.64%
GSK
+5.21%
Max(CAGR)
Winner
SNY
+5.49%
GSK
+3.17%

SNY vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearSNYGSK
2026-4.11%+6.95%
2025+5.02%+50.62%
2024+0.50%-6.27%
2023+5.32%+9.25%
2022-0.66%-32.73%
2021+6.62%+23.62%
2020-0.53%-17.52%
2019+22.08%+30.36%
2018+5.16%+9.29%
2017+8.38%-3.80%
2016-0.09%+1.52%
2015-3.26%+0.48%
2014-8.70%-14.73%
2013+15.70%+26.97%
2012+33.41%-0.75%
2011+15.20%+22.51%
2010-17.19%-3.72%
2009+26.74%+20.27%
2008-26.44%-21.93%
2007+1.12%-2.77%
2006+2.95%+6.93%
2005+11.84%+9.96%
2004+8.64%+5.08%
2003+24.88%+25.04%
2002+2.12%-22.83%
2001N/A-9.58%
2000N/A+5.67%
1999N/A-5.78%

SNY vs GSK Drawdown Comparison

The maximum drawdown for SNY was -46.47%, occurring on Mar 6, 2009. Recovery took 1512 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current SNY drawdown is -18.72%. The current GSK drawdown is -13.24%.

RankSNYGSK
#1-46.47%
Jul 26, 2006 - Jul 26, 2012
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-33.52%
May 24, 2022 - Apr 13, 2023
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-30.85%
Sep 22, 2014 - Oct 30, 2019
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-28.97%
Aug 9, 2002 - May 29, 2003
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-26.40%
Feb 6, 2020 - Jun 2, 2020
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-26.32%
Jan 22, 2004 - Nov 5, 2004
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-23.37%
Mar 6, 2025 - Mar 13, 2026
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-21.87%
Sep 20, 2023 - Jul 25, 2024
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-21.60%
Sep 4, 2024 - Mar 5, 2025
-10.52%
May 16, 2006 - Feb 13, 2007
#10-20.37%
Jun 18, 2003 - Nov 18, 2003
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-17.09%
Jul 8, 2002 - Aug 7, 2002
-8.45%
May 28, 2013 - Nov 1, 2013
#12-15.75%
Jul 20, 2020 - May 10, 2021
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-14.04%
May 28, 2013 - Jun 4, 2014
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-13.24%
Jun 14, 2021 - Apr 7, 2022
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-12.65%
May 26, 2005 - Dec 23, 2005
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between SNY and GSK is 0.87 which considered as a strong positive correlation - the stocks tend to move together.

0.87
-101

Dividend Comparison (2000 - 2026)

SNY vs GSK dividend yield comparison.

YearSNYGSK
20265.53%1.69%
20254.57%3.42%
20244.22%4.60%
20233.83%3.75%
20224.32%5.47%
20213.80%4.99%
20203.61%5.59%
20193.47%4.35%
20184.29%5.65%
20173.82%5.83%
20164.11%6.86%
20153.77%5.93%
20144.19%6.20%
20133.34%4.51%
20123.71%5.70%
20113.62%4.83%
20104.55%5.10%
20093.66%4.39%
20085.05%5.74%
20072.56%4.09%
20061.77%3.29%
20051.42%3.03%
20042.52%3.38%
20032.21%2.77%
20020.00%3.10%
20010.00%1.54%
20000.00%4.57%

Select Stocks to Compare